Diagnostic Work‑up for New Ascites in Patients with Known Liver Metastases
Immediate Paracentesis
- Perform diagnostic paracentesis at the bedside as soon as new‑onset ascites is identified; it is the fastest, most cost‑effective way to determine etiology and can be done safely even in the presence of coagulopathy, with serious complications in only ~1 % of procedures (mostly minor abdominal wall hematomas). AASLD [1][2]
Ascitic Fluid Laboratory Panel
Core Tests (required for every tap)
- Cell count with differential – a neutrophil count > 250 cells/mm³ defines spontaneous bacterial peritonitis (SBP); a lymphocyte‑predominant fluid suggests tuberculous peritonitis or peritoneal carcinomatosis. AGA 3
- Ascitic and serum albumin – enables calculation of the serum‑ascites albumin gradient (SAAG). AASLD 2
- Culture in blood‑culture bottles inoculated at bedside – the most sensitive method to exclude infection. AASLD 1; AGA 3
Context‑Driven Add‑on Tests
- Amylase – order when pancreatic ascites is suspected. AGA 3
Concurrent Blood Tests
- Brain natriuretic peptide (BNP) – median pro‑BNP ≈ 6 100 pg/mL in heart‑failure‑related ascites versus ≈ 166 pg/mL in cirrhotic ascites, helping to identify cardiac ascites. AASLD 1
Interpretation of SAAG
| SAAG Value | Interpretation & Typical Causes | Evidence |
|---|---|---|
| ≥ 1.1 g/dL (portal hypertension) – 97 % accuracy | • Massive liver metastases causing portal hypertension • Tumor‑related portal vein thrombosis • Budd‑Chiari syndrome (hepatic vein thrombosis) | AASLD [2][1] |
| < 1.1 g/dL (no portal hypertension) | • Peritoneal carcinomatosis (common when liver involvement is not massive) • Nephrotic syndrome | AASLD [1] |
When cytology is positive despite a SAAG ≥ 1.1 g/dL, the patient has “mixed ascites” (concurrent portal hypertension and peritoneal carcinomatosis).
Imaging Recommendations
- Abdominal imaging (CT or MRI) – assess the extent of liver metastases, detect portal‑vein tumor thrombus, evaluate hepatic‑vein thrombosis (Budd‑Chiari), and screen for hepatocellular carcinoma when underlying cirrhosis is present. AASLD 1
- Ultrasound – useful to confirm the presence of ascites when physical examination is equivocal (e.g., in obesity), but it cannot determine the underlying cause. AASLD 1; AASLD 2
Critical Pitfalls to Avoid
- Do not postpone paracentesis because physical signs (e.g., shifting dullness) require ≥ 1 500 mL of fluid and cannot establish etiology. AASLD [1][2]
- Do not correct coagulopathy prophylactically (e.g., with fresh‑frozen plasma or platelets) before paracentesis; bleeding complications are rare (~0.1 % or 1 / 1 000 procedures). AASLD [1][2]
- Always obtain a cell count and treat SBP promptly when neutrophils exceed 250 cells/mm³, even in malignant ascites. AGA 3
All facts above are drawn from peer‑reviewed guidelines and studies cited as 1, 2, and 3.
Diagnosis and Management of Ascites
Diagnostic Approach
- The American Association for the Study of Liver Diseases recommends performing a diagnostic paracentesis immediately in all patients with new-onset ascites or worsening abdominal fluid accumulation, as this is the single most important diagnostic and potentially life-saving intervention 4, 5.
- Physical examination findings, such as shifting dullness, have 83% sensitivity and require at least 1,500 mL of fluid to be detectable, while jugular venous distension indicates cardiac ascites rather than cirrhotic ascites 6.
Laboratory Analysis
- The European Association for the Study of the Liver recommends sending ascitic fluid for neutrophil count, with >250 cells/mm³ diagnosing spontaneous bacterial peritonitis (SBP) requiring immediate antibiotics, and total protein and albumin to calculate the serum-ascites albumin gradient (SAAG) 7, 8.
- A SAAG ≥1.1 g/dL indicates portal hypertension with 97% accuracy, which is the key diagnostic calculation 8.
Treatment of Ascites
- The American College of Gastroenterology recommends performing therapeutic paracentesis as first-line treatment for tense or gross ascites, removing all accessible fluid in a single session, and administering albumin at 8 g per liter of ascites removed when removing >5 liters to prevent post-paracentesis circulatory dysfunction 5.
- Dietary sodium restriction to 2 g/day and diuretic therapy with spironolactone and furosemide are also recommended, with monitoring of serum potassium, creatinine, and electrolytes 5.
Management of Refractory Ascites
- The European Association for the Study of the Liver defines refractory ascites as ascites that cannot be mobilized or recurs ≥3 times within 12 months despite sodium restriction and maximum diuretics, and recommends repeated large-volume paracentesis with albumin replacement or transjugular intrahepatic portosystemic shunt (TIPS) in selected patients 5, 9.